Utility of quantitative measurement of T 2 using restriction spectrum imaging for detection of clinically significant prostate cancer von Rojo Domingo, Mariluz, Conlin, Christopher C, Karunamuni, Roshan, Ollison, Courtney, Baxter, Madison T, Kallis, Karoline, Do, Deondre D, Song, Yuze, Kuperman, Joshua, Shabaik, Ahmed S, Hahn, Michael E, Murphy, Paul M, Rakow-Penner, Rebecca, Dale, Anders M, Seibert, Tyler M

Volltext

Utility of quantitative measurement of T2 using restriction spectrum imaging for detection of clinically significant prostate cancer von Rojo Domingo, Mariluz, Conlin, Christopher C., Karunamuni, Roshan, Ollison, Courtney, Baxter, Madison T., Kallis, Karoline, Do, Deondre D., Song, Yuze, Kuperman, Joshua, Shabaik, Ahmed S., Hahn, Michael E., Murphy, Paul M., Rakow-Penner, Rebecca, Dale, Anders M., Seibert, Tyler M.

Volltext

Quantitative MRI biomarker for classification of clinically significant prostate cancer: Calibration for reproducibility across echo times von Kallis, Karoline, Conlin, Christopher C., Ollison, Courtney, Hahn, Michael E., Rakow‐Penner, Rebecca, Dale, Anders M., Seibert, Tyler M.

Volltext